Skip to content

Polaryx Therapeutics, Inc. PLYX Convertible Preferred Stock Issued Shares

Convertible Preferred Stock Issued Shares at other companies

Las Vegas Sands logo
Las Vegas SandsLVS
0
Henry (Jack) & Associates logo
Henry (Jack) & AssociatesJKHY
0
Citigroup logo
CitigroupC
782K+6.5%
Stifel Financial logo
Stifel FinancialSF
27.4K0.0%
Wells Fargo & Company logo
Wells Fargo & CompanyWFC
4.6M-2.8%
RBC Bearings logo
RBC BearingsRBC
0

Other financials

Income statement

See full
Operating income-$2.0M+61.2%
Net income-$2.5M+49.6%
EPS (diluted)-$0.05+54.5%

Balance sheet

See full
Cash & equivalents$3.1M+1,132%
Total equity$2.5M-41.5%
Total assets$3.5M

Cash flow

See full
Operating cash flow-$2.1M-191%

Valuation

See full
Market cap$115.64M

Returns & leverage

See full
Return on equity-1,209.8%
Current ratio3.5×

Where this comes from

Reported directly by Polaryx Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesIssued.

The official record: Polaryx Therapeutics, Inc. ’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Polaryx Therapeutics, Inc. 's convertible preferred stock issued shares.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Polaryx Therapeutics, Inc. 's convertible preferred stock issued shares?
Polaryx Therapeutics, Inc. (PLYX) reported convertible preferred stock issued shares of $0 in Q4 2025.
What does convertible preferred stock issued shares mean?
Number of convertible preferred shares that have been issued, whether held by investors or in treasury.